130 related articles for article (PubMed ID: 11862771)
1. [Reversible posterior leukoencephalopathy in a patient with non-Hodgkin's lymphoma after treatment with CHOP].
Giménez-Mesa E; Martínez-Salio A; Porta-Etessam J; Berbel García A; Cedena Romero T; Salama Bendoyan P
An Med Interna; 2001 Nov; 18(11):591-3. PubMed ID: 11862771
[TBL] [Abstract][Full Text] [Related]
2. Fatal leukoencephalopathy in a patient with non-Hodgkin's lymphoma treated with CHOP chemotherapy and high-dose steroids.
Cain MS; Burton GV; Holcombe RF
Am J Med Sci; 1998 Mar; 315(3):202-7. PubMed ID: 9519935
[TBL] [Abstract][Full Text] [Related]
3. [Posterior reversible encephalopathy syndrome following paralytic ileus caused by vincristine in a patient with T cell lymphoblastic lymphoma].
Hayase E; Sugita J; Fujimoto K; Ebata K; Yamakawa T; Yoshida M; Takemura R; Iwasaki J; Takahashi S; Shiratori S; Kondo T; Tanaka J; Teshima T
Rinsho Ketsueki; 2014 Feb; 55(2):249-53. PubMed ID: 24598194
[TBL] [Abstract][Full Text] [Related]
4. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
[TBL] [Abstract][Full Text] [Related]
5. Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.
Hosoi M; Yamamoto G; Imai Y; Kurokawa M
Ann Hematol; 2010 Feb; 89(2):207-8. PubMed ID: 19582454
[No Abstract] [Full Text] [Related]
6. Necrotizing leukoencephalopathy following CHOP chemotherapy.
Blaes AH; Santa-Cruz KS; Lee CK; Hui SK; Peterson BA
Leuk Res; 2008 Oct; 32(10):1611-4. PubMed ID: 18378307
[TBL] [Abstract][Full Text] [Related]
7. Reversible posterior leukoencephalopathy syndrome after treatment of diffuse large B-cell lymphoma.
Haefner MD; Siciliano RD; Widmer LA; Vogel Wigger BM; Frick S
Onkologie; 2007 Mar; 30(3):138-40. PubMed ID: 17341901
[TBL] [Abstract][Full Text] [Related]
8. [Nasal NK cell lymphoma with hemophagocytic syndrome developed tumor lysis syndrome after CHOP therapy].
Sawada M; Yamada T; Tsurumi H; Moriwaki H
Rinsho Ketsueki; 2002 Nov; 43(11):988-92. PubMed ID: 12508484
[TBL] [Abstract][Full Text] [Related]
9. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
[TBL] [Abstract][Full Text] [Related]
10. Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma.
Edwards MJ; Walker R; Vinnicombe S; Barlow C; MacCallum P; Foran JM
Ann Oncol; 2001 Sep; 12(9):1327-9. PubMed ID: 11697848
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
[TBL] [Abstract][Full Text] [Related]
12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
13. [Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].
Hou M; Li L; Qiu M; Yan X; Zhu J; Gou HF
Ai Zheng; 2005 Apr; 24(4):461-4. PubMed ID: 15820070
[TBL] [Abstract][Full Text] [Related]
14. Images in haematology. Irreversible blindness secondary to posterior reversible encephalopathy syndrome following CHOP combination chemotherapy.
Hemmaway C; Mian A; Nagy Z
Br J Haematol; 2010 Jul; 150(2):129. PubMed ID: 20487440
[No Abstract] [Full Text] [Related]
15. Acute posterior leukoencephalopathy in a patient with nephrotic syndrome.
Utsumi K; Amemiya S; Iizuka M; Iino Y; Katayama Y
Clin Exp Nephrol; 2003 Mar; 7(1):63-6. PubMed ID: 14586746
[TBL] [Abstract][Full Text] [Related]
16. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
[TBL] [Abstract][Full Text] [Related]
17. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
19. [Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma].
Yuan ZY; Xu RH; He YJ; Guan ZZ
Ai Zheng; 2003 Apr; 22(4):393-6. PubMed ID: 12703996
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
